Journal article
Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelination
H Peckham, L Giuffrida, R Wood, D Gonsalvez, A Ferner, TJ Kilpatrick, SS Murray, J Xiao
GLIA | Published : 2016
DOI: 10.1002/glia.22927
Abstract
Fyn, a member of the Src family of nonreceptor tyrosine kinases, promotes central nervous system myelination during development; however the mechanisms mediating this effect remain unknown. Here we show that Fyn phosphorylation is modulated by BDNF in vivo. Concordant with this, we find that BDNF stimulates Fyn phosphorylation in myelinating cocultures, an effect dependent on oligodendroglial expression of TrkB. Importantly, PP2, a pharmacological inhibitor of Src family kinases, not only abrogated the promyelinating influence of BDNF in vitro, but also attenuated BDNF-induced phosphorylation of Erk1/2 in oligodendrocytes. Over-expression of Fyn in oligodendrocytes significantly promotes pho..
View full abstractRelated Projects (2)
Grants
Awarded by Australian National Health and Medical Research Council
Awarded by National Multiple Sclerosis Society (USA)
Awarded by Multiple Sclerosis Research Australia Project Fund
Funding Acknowledgements
Grant sponsor: The Australian National Health and Medical Research Council grants; Grant number: #628761, #APP1058647; Grant sponsor: National Multiple Sclerosis Society (USA); Grant number: #RG 4309A5/2; Grant sponsor: Multiple Sclerosis Research Australia Project Fund; Grant number: #13039; Grant sponsor: The University of Melbourne Research CI Fellowship.